Considering the important role of COX-1-derived PGs and COX-2/PGs in pro-inflammatory promotion, poor COX-1 inhibition improves COX-2-specific inhibition and may be a suitable approach for cancer therapeutics. Here, PTGS2 is linked to cancer.